On September 23, 2022, David L. Kemmerly resigned as Chief Legal and Government Affairs Officer of Amedisys, Inc., effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.2 USD | -0.59% | +1.32% | +1.20% |
04-24 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
04-24 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.20% | 3.14B | |
0.00% | 1.96B | |
+17.44% | 1.76B | |
+62.79% | 681M | |
-11.30% | 460M | |
-13.81% | 184M | |
-17.65% | 131M | |
+3.85% | 69.15M |
- Stock Market
- Equities
- AMED Stock
- News Amedisys, Inc.
- Amedisys, Inc. Announces Resignation of David L. Kemmerly as Chief Legal and Government Affairs Officer